| scholarly article | Q13442814 |
| P50 | author | Govind Bhagat | Q38546986 |
| Wenju Chang | Q57007683 | ||
| Aesis Luna | Q87084343 | ||
| P2093 | author name string | Anil K Rustgi | |
| Kenneth K Wang | |||
| Timothy C Wang | |||
| Julian A Abrams | |||
| Hongshan Wang | |||
| Yoku Hayakawa | |||
| Andrea Varro | |||
| Antonia R Sepulveda | |||
| Aleksandra M Urbanska | |||
| Richard A Friedman | |||
| Michael Quante | |||
| Malcolm Boyce | |||
| Guangchun Jin | |||
| Yoomi Lee | |||
| Andrew S Au | |||
| P2860 | cites work | Identification of stem cells in small intestine and colon by marker gene Lgr5 | Q28131701 |
| G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo | Q28512542 | ||
| Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas | Q30544316 | ||
| The gastrins: their production and biological activities | Q31963664 | ||
| A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus | Q33305126 | ||
| Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus | Q33905941 | ||
| American Gastroenterological Association medical position statement on the management of Barrett's esophagus | Q34168686 | ||
| Incidence of adenocarcinoma among patients with Barrett's esophagus | Q34223900 | ||
| Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis | Q34352867 | ||
| Prevalence of Barrett's esophagus in the general population: an endoscopic study | Q34475247 | ||
| Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus | Q35116562 | ||
| Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus | Q35353336 | ||
| CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis | Q36232937 | ||
| Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo | Q36477468 | ||
| Cholecystokinin-B/gastrin receptors enhance wound healing in the rat gastric mucosa | Q37271046 | ||
| Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005 | Q37330745 | ||
| Processing and proliferative effects of human progastrin in transgenic mice | Q37360937 | ||
| Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients | Q39234055 | ||
| Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis | Q39455544 | ||
| Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model | Q39773312 | ||
| Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. | Q40671403 | ||
| The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands | Q41995266 | ||
| An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagus | Q42458715 | ||
| Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK | Q42836024 | ||
| Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor | Q44337871 | ||
| Changes in gene expression of gastric mucosa during therapeutic acid inhibition | Q46446608 | ||
| Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. | Q46531991 | ||
| Effect of acid suppression on molecular predictors for esophageal cancer | Q46956128 | ||
| Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. | Q48955058 | ||
| Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. | Q52527069 | ||
| Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
| Serum gastrin levels during long-term omeprazole treatment | Q67263774 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year | Q83562718 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholecystokinin | Q60315441 |
| P304 | page(s) | 203-214 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus | |
| P478 | volume | 8 |
| Q46360679 | A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance |
| Q49788912 | Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer |
| Q52715285 | Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine. |
| Q92761225 | Esophageal cancer research today and tomorrow: Lessons from algae and other perspectives |
| Q58582260 | Gastric Stem Cell and Cellular Origin of Cancer |
| Q90110440 | Hormonal Suppression of Stem Cells Inhibits Symmetric Cell Division and Gastric Tumorigenesis |
| Q54940434 | Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance. |
| Q47107972 | Metaplasia in the Stomach-Precursor of Gastric Cancer? |
| Q64917588 | Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality? |
| Q55302559 | Organoids Provide an Important Window on Inflammation in Cancer. |
| Q89285887 | Origins of Metaplasia in the Esophagus: Is This a GE Junction Stem Cell Disease? |
| Q50010294 | Patient-derived organoid models help define personalized management of gastrointestinal cancer |
| Q33600436 | The Origins of Gastric Cancer From Gastric Stem Cells: Lessons From Mouse Models. |
| Q98944980 | Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor |
| Q50475132 | Unique Cellular Lineage Composition of the First Gland of the Mouse Gastric Corpus. |
Search more.